Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anaptysbio Inc (ANAB)

Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anaptysbio Inc 10770 WATERIDGE CIRCLE SUITE 210 SAN DIEGO CA 92121 USA

www.anaptysbio.com Employees: 136 P: 858-362-6295

Sector:

Medical

Description:

AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 1,384,676
Enterprise Value, $K 1,261,596
Shares Outstanding, K 27,688
Annual Sales, $ 91,280 K
Annual Net Income, $ -145,230 K
Last Quarter Sales, $ 76,320 K
Last Quarter Net Income, $ 15,110 K
EBIT, $ -28,680 K
EBITDA, $ -36,600 K
60-Month Beta 0.29
% of Insider Shareholders 33.50%
Float, K 18,413
% Float 66.50%
Short Interest 5,863
Short Float 21.17%
Short Volume Ratio 0.36

Growth:

1-Year Return 260.04%
3-Year Return 61.37%
5-Year Return 132.60%
5-Year Revenue Growth 1,041.00%
5-Year Earnings Growth -42.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.52 on 11/04/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -2.82
EPS Growth vs. Prev Qtr 138.81%
EPS Growth vs. Prev Year 145.61%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ANAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,101.24%
Return-on-Assets % -21.23%
Profit Margin % -159.10%
Debt/Equity 0.00
Price/Sales 15.18
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.06
Interest Coverage -2.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar